Kaposi's sarcoma (Therapy)
"Randomized Cross-Over Comparison of Liposomal Daunorubicin Versus Observation for Early Kaposi's sarcoma."
Published in Cancer Weekly, June 17th, 1996
According to the authors' abstract of an article published in AIDS, "Objectives: To evaluate single-agent liposomal daunorubicin chemotherapy in the management of early HIV-related Kaposi's sarcoma (KS). Design: Randomized cross-over comparison of liposomal daunorubicin versus observation. Setting: Study conducted at single site in tertiary referral HIV unit. Patients: Twenty-nine HIV-seropositive men with <20 cutaneous KS, no visceral involvement and CD4 cell counts < 400x106/L were randomized. Adequate haematological, hepatic and renal function was required for entry. A left ventricular ejection fraction of >45% was necessary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (1996-06-17)
More Articles from Cancer Weekly
- Epidemiology (HCV)
HCV Most Common Cause of Liver Cancer in Japan, But Not Hawaii - Antisense Technology
Anti-Tumor Activity Demonstrated in Models of Human Cancer - Bladder Cancer
Tool for Cancer Management Provided - Blood Substitutes
Project Announced To Develop PHER-O2 - Brain Cancer (Therapy)
Patient Enrollment Completed in Phase II RMP-7 Tumor Studies - Breast Cancer (Clinical Trials)
Trial Aims to Improve Survival/Quality of Life for Women with Cancer - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
